ANI Pharmaceuticals, Inc. (ANIP)
74.04
-1.56
(-2.06%)
USD |
NASDAQ |
Mar 06, 16:00
74.11
+0.07
(+0.09%)
After-Hours: 20:00
ANI Pharmaceuticals SG&A Expense (TTM) : 234.96M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| CorMedix, Inc. | 60.19M |
| Castle Biosciences, Inc. | 229.32M |
| Assertio Holdings, Inc. | 63.52M |
| Arcutis Biotherapeutics, Inc. | 274.55M |
| Allogene Therapeutics, Inc. | 58.53M |